Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
November 20, 2018 08:30 ET
|
Zenith Capital Corp.
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019 CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zenith...
GWG Holdings Reports Results for the Third Quarter Ended September 30, 2018
November 19, 2018 16:30 ET
|
GWG Holdings, Inc.
GWGH Announces Share Repurchase Program MINNEAPOLIS, Nov. 19, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), a leading provider of liquidity to consumers owning life insurance...
GWG Holdings to Report Third Quarter 2018 Financial Results on November 13, 2018
October 30, 2018 16:30 ET
|
GWG Holdings, Inc.
MINNEAPOLIS, Oct. 30, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), the parent company of GWG Life, Life Epigenetics and YouSurance, subsidiaries that are transforming the alternative...
Jon Sabes, CEO of YouSurance, Presented at Plug and Play Event about Insurtech and Health Data
October 18, 2018 16:20 ET
|
GWG Holdings, Inc.; YouSurance
MINNEAPOLIS, Oct. 18, 2018 (GLOBE NEWSWIRE) -- YouSurance, an insurtech company working to apply epigenetic signatures to assess life insurance applicants’ health and lifespan, announced that its...
YouSurance is First to Assess Health and Lifespan Using Epigenetic Biomarkers for Life Insurance Applicants
October 02, 2018 09:00 ET
|
GWG Holdings, Inc.
MINNEAPOLIS, Oct. 02, 2018 (GLOBE NEWSWIRE) -- YouSurance, a digital managing general agency (MGA), is the first company to use epigenetic biomarkers to assess life insurance applicants’ health and...
Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award
September 12, 2018 09:00 ET
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today congratulated Dr. C. David Allis and Dr. Michael Grunstein, the co-recipients of the...
Constellation Pharmaceuticals Announces Appointments to Board of Directors
September 04, 2018 06:30 ET
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and...
GWG Holdings Reaches Key Milestone of More Than 1,000 Policies in its Life Insurance Portfolio
July 19, 2018 17:00 ET
|
GWG Holdings, Inc.
MINNEAPOLIS, July 19, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), the parent company of GWG Life, a financial services company that is transforming the life insurance industry through...
Constellation Pharmaceuticals Announces Pricing of Initial Public Offering
July 18, 2018 19:56 ET
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (the “Company”)(Nasdaq:CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to...
BioAdaptives, Inc Names Dr. James Rouse as President
May 15, 2018 09:00 ET
|
BioAdaptives Inc.
LAS VEGAS, May 15, 2018 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC PINK:BDPT) announced Dr. James Rouse has been appointed to the board of Directors and accepted the position of President. He will...